Question

Discuss the development of new drugs in the United States as compared to other countries, and evaluate the pharmacoeconomic issues that lead to high prescription costs in the United States.

Answer 1

U.S. Pharmaceutical sector is the largest in the world. Valued around $466 billions Important phares for adung overall is its food and drug Administration. → Every country undergoes a strict Proces before Inventing a drig but their may be slight changes in the Phases as well. En U.S.A - Phase 1 Discovery and development Phase - 2 Preclinical Research, Phase 3 clinical Research Phase: 4 FDA Review Phase:- 5 FDA post marketing safety marketing Every country has their own Regulatory authority. for example: India – Cosco Canada - Health canada, Scanned with

But finally maximum countries undergoes USADA Inspection for a new deweg development Phoolona Coeconomic Resues on high cost of prescription drugs :- → U.S has significantly higher prices than the rest of developed world when come to prescription drugs 0 Limited competition among drug Companies ② Pharmacy benefit managers may be driven by profit maximization 3 Lowering drug profits would make pharmaceuticals Les desirable Industry for Inventors' @ High costs is due to Expanding the I Rights of patents CS